Toxicology of Industrial Compounds

P.SAGELSDORFF 89
SHUGART, L. and KAO, J., 1985, Examination of adduct formation in vivo in the
mouse between benzo[a]pyrene and DNA of skin and haemoglobin of red
blood cells. Environm. Health Perspect., 62, 223–6.
VAN SITTERT, N.J., DE JONG, G., CLARE, M.G., DAVIES, R., DEAN, B.J.,
WREN, L.J. and WRIGHT, A.S., 1985, Cytogenetic, immunological and
haematological effects in workers in an ethylene oxide manufacturing plant,
Br. J. Ind. Med., 42, 19–46.
SKIPPER, P.L. and TANNENBAUM, S.R., 1990, Protein adducts in molecular
dosimetry of chemical carcinogens, Carcinogenesis, 11, 507–18.
STEINER, S., CRANE, A.E. and WATSON, W.P., 1992a, Molecular dosimetry of
DNA adducts in C3H mice treated with glycidaldehyde, Carcinogenesis, 13,
119– 24.
STEINER, S., HÖNGER, G. and SAGELSDORFF, P., 1992b, Molecular dosimetry
of DNA adducts in C3H mice treated with bisphenol A diglycidylether,
Carcinogenesis, 13, 969–72.
TÖRNQVIST, M., MOWRER, J., JENSEN, S. and EHRENBERG, L., 1986,
Monitoring of environmental cancer initiators through haemoglobin adducts
by a modified Edman degradation method, Anal. Biochem., 154, 255–66.
WEISSBURGER, J.H. and WILLIAMS, G.N., 1975, Metabolism of chemical
carcinogens, in Becker, F.F. (Ed.), Cancer, Vol. 1, pp. 185–234, New York:
Plenum.
WESTON, A., BOWMAN, E.D., ROWE, M.L., MANCHESTER, D.K. and
HARRIS, C.C., 1989, Fluorescence and mass spectral evidence for the
formation of benzo[a]pyrene anti-diol-epoxide-DNA and -haemoglobin
adducts in humans, Carcinogenesis, 10, 251–7.